Item | Days | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
−7 | – | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | – | 14 | – | 21 | |
Eligibility screen | × | |||||||||||||
Informed consent | × | |||||||||||||
Baseline | × | × | × | |||||||||||
Allocation | × | |||||||||||||
Pediatric Tuina | × | × | × | × | ||||||||||
Medilac-Vita | × | × | × | × | × | × | × | |||||||
Follow-up | × | × | × | × | × | |||||||||
Stool dairy | × | × | × | × | × | × | × | × | × | × | × | × | × | × |
Assessment | ||||||||||||||
SBMs | × | × | × | × | ||||||||||
CSBMs | × | × | × | × | ||||||||||
Effective rate | × | × | × | × | ||||||||||
m-BSFS | × | × | × | × | ||||||||||
Distress sensation | × | × | × | × | ||||||||||
Glycerine enema rate | × | × | × | × | ||||||||||
Participants safety | ||||||||||||||
Adverse events | × | × | × | × | × | × | × | × | × | × | × | × |